The popular weight-loss and diabetes drugs could play a significant role not only in disease prevention, but possibly in ...

Metabolic hypogonadism, a condition marked by low testosterone levels and frequently seen in obese individuals, contributes to worsening metabolic health and an increased risk of type 2 diabetes.

GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...

India's anti-obesity drug market is valued at Rs 3,000-3,500 crore and is projected to grow nearly eightfold to Rs 25,000 ...

More than 80 U.S. lawmakers asked the FDA to stop counterfeit GLP-1 drugs linked to Chinese suppliers from entering the ...

The incretin-based therapies reduced mortality and hospitalization risk in individuals with heart failure with preserved ...

Researchers in a recent study discovered that people taking medications to help them lose weight might experience weight gain ...

A new Mounjaro user has opened up on their experience taking the drug - including the one side effect they're struggling with ...

The illicit supply of unregulated weight loss drugs is becoming an ‘emerging concern’ for Police Scotland and the.

Once scorned as a cosmetic lifestyle disfigurement, obesity today is recognised as a chronic and progressive disease. From the altered metabolic deran.